PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED
on 02 Jan 2024
Last Applicant/ Owned by
9-7-2 AKASAKA MINATO-KU
TOKYO
JP
107-0052
Serial Number
86577541 filed on 26th Mar 2015
Registration Number
5239010 registered on 11th Jul 2017
Correspondent Address
Rebecca Liebowitz
Filing Basis
1. intent to use
Disclaimer
NO DATA
HEPTARES
Biotechnology testing, namely, genetic testing for scientific research purposes; Biotechnology research; Biotechnology development, namely, development in the field of drug discovery and biopharmaceuticals; biotechnology advice; Biotechnology consultancy; Biotechnology information, namely, providing information on the subject of scientific research in the field of biotechnology; Pharmaceutical tes Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Pharmaceutical advice; pharmaceutical consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Biotechnology testing, namely, genetic testing for scientific research purposes; Biotechnology research; Biotechnology development, namely, development in the field of drug discovery and biopharmaceuticals; biotechnology advice; Biotechnology consultancy; Biotechnology information, namely, providing information on the subject of scientific research in the field of biotechnology; Pharmaceutical testing; pharmaceutical research; pharmaceutical development; pharmaceutical consultancy for non-medical purposes; Providing medical and scientific research information in the fields of pharmaceuticals; scientific testing and research in the pharmaceutical and biopharmaceutical fields, namely, chemical and biological drug discovery services; providing scientific information, advice, and consultancy in the field of technologies related to proteins, including transmembrane proteins and G-proteins, and G protein coupled receptors, and parts thereof; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; Research and development in the pharmaceutical and biopharmaceutical fields, namely, technologies related to proteins and G protein coupled receptors; biology and chemistry services, namely, research and consulting in the field of chemistry and biology; pharmaceutical research services, namely, chemical and biological drug discovery services; research and development services for pharmaceutical lead identification; synthetic chemistry consultation services and research; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for non-medical screening purposes; research, analysis and identification of compounds through automated screening processes research and development services relating to pharmaceutical research services, namely, chemical and biological drug discovery services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
[ Biological products for medical purposes, namely, g-protein-coupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, proteins, G-protein-coupled receptors, transmembrane proteins, G-Proteins, antibodies and peptides and parts thereof, for therapeutic purposes; chemicals, proteins and parts thereof for use in medical diagnostics; none being dietetic substances adapted for medical use or food products ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
[ Chemicals and proteins used in research, namely, for chemistry and biological drug discovery, lead identification and diagnostics; proteins including G-protein-coupled receptors, trans-membrane proteins and parts thereof, for use in pharmaceutical research, namely, drug discovery purposes ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 86577541
Mark Type
No Service Mark
Attorney Docket Number
No 18634-570951
44D Filed
No
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Jul 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 02th Jan 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 02th Jan 2024 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 02th Jan 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 10th Jul 2023 | TEAS SECTION 8 & 15 RECEIVED |
| 11th Jul 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 06th May 2020 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 30th Oct 2018 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 30th Oct 2018 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 11th Jul 2017 | REGISTERED-PRINCIPAL REGISTER |